"remember ph2 trials have a historical average of 20% success"
Are you sure - that sounds far too low?
In the area of tbi - The success rate was 0% for a long time. Hence lots of pharma companies gave up looking. So areas like this bring the success rate down.
What I like about ftt's drug is that it helps the patient to heal themselves.
"remember ph2 trials have a historical average of 20% success"...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
